Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPets at home Regulatory News (PETS)

Share Price Information for Pets at home (PETS)

Share Price is delayed by 15 minutes
Get Live Data
179.40    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.30 (0.167%)
Market Cap: £793.45m
PETS Live PriceLast checked at - London Stock Exchange

Intraday Pets at home Share Chart

Commencement of Share Buy-Back Programme

26 Jun 2023 07:00

RNS Number : 7997D
Pets At Home Group Plc
26 June 2023
 

FOR IMMEDIATE RELEASE, 26 June 2023

PETS AT HOME GROUP PLC

 

Pets at Home Group Plc: Commencement of Share Buy-Back Programme

 

 

Following the commitment made in the preliminary announcement of its results for the year ended 30 March 2023 (the "Results Announcement"), Pets at Home Group plc (the "Company") is pleased to announce the commencement of a £50 million share buyback programme (the "Programme"). The Programme will be undertaken in two tranches. In respect of the first tranche of the Programme, the Company announces that it has entered into non-discretionary instructions with Numis Securities Limited ("Numis") to conduct a share buyback programme on the Company's behalf and to make trading decisions independently of the Company (the "First Tranche Programme").

Under the terms of the engagement with Numis, the First Tranche Programme will be for maximum aggregate consideration of £25 million. The First Tranche Programme will commence today, 26 June 2023, and will end on or before 29 September 2023. The sole purpose of the Programme is to reduce the Company's share capital. The board of directors of the Company (the "Board") has decided that the shares purchased pursuant to the Programme will be cancelled.

The Programme will take place within the limitations of the authority granted to the Board of the Company by shareholders at its annual general meeting held on 7 July 2022, pursuant to which the maximum number of shares to be bought back by the Company is 50,000,000, and is conditional on the renewal of such authority at the Company's 2023 annual general meeting, to be held on 6 July 2023. The Programme will be in accordance with the UK version of the EU Market Abuse Regulation (596/2014) and the Commission Delegated Regulation (2016/1052), which are incorporated into English law by virtue of the European Union (Withdrawal) Act 2018, and Chapter 12 of the Financial Conduct Authority's Listing Rules.

The second tranche of the Programme is expected to be undertaken by HSBC Bank plc. Further details in respect of these arrangements will be announced in due course.

 

LEI: 2138003Y9ULD24PD3J93

 

Enquiries

Pets at Home Group Plc:

+44 (0) 161 486 6688

 

Lucy Williams, Company Secretary

 

Investor Relations Enquiries

 

Chris Ridgway, Head of Investor Relations

+44 (0)7788 783925

 

Media Enquiries

 

Natalie Cullington, Head of Media & Corporate Affairs

+44 (0)7974 594 701

 

About Pets At Home

Pets at Home Group Plc is the UK's leading pet care business; our commitment is to make sure pets and their owners get the very best advice, products and care. Pet products are available online or from our 457 stores, many of which also have vet practices and grooming salons. Pets at Home also operates a UK leading small animal veterinary business, with 444 First Opinion practices located both in our stores and in standalone locations. For more information visit: http://investors.petsathome.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBLGDLSDDDGXX
Date   Source Headline
30th Jun 20227:00 amRNSTransaction in Own Shares
29th Jun 20227:00 amRNSTransaction in Own Shares
28th Jun 20227:00 amRNSTransaction in Own Shares
27th Jun 20229:08 amRNSTransaction in Own Shares
24th Jun 20227:00 amRNSTransaction in Own Shares
23rd Jun 20222:04 pmRNSDirector/PDMR Shareholding
23rd Jun 20227:00 amRNSTransaction in Own Shares
22nd Jun 202211:52 amRNSTransaction in Own Shares
21st Jun 20229:02 amRNSTransaction in Own Shares
20th Jun 20227:00 amRNSCommencement of Share Buy-Back Programme
10th Jun 20227:00 amRNSAnnual Report & Accounts and Notice of AGM
8th Jun 20223:21 pmRNSDirector/PDMR Shareholding
8th Jun 202210:17 amRNSDirector/PDMR Shareholding
8th Jun 202210:15 amRNSDirector/PDMR Shareholding
8th Jun 202210:15 amRNSDirector/PDMR Shareholding
8th Jun 202210:13 amRNSDirector/PDMR Shareholding
7th Jun 20227:00 amRNSDividend Declaration
6th Jun 202211:18 amRNSDirector/PDMR Shareholding
1st Jun 20225:02 pmRNSDirector/PDMR Shareholding
1st Jun 20225:02 pmRNSDirector/PDMR Shareholding
1st Jun 20227:00 amRNSAppointment of CEO
27th May 20228:36 amRNSDirector/PDMR Shareholding
26th May 20227:04 amRNSDirector/PDMR Shareholding
25th May 202210:00 amRNSFinal Results
29th Mar 20223:15 pmRNSHolding(s) in Company
8th Mar 20229:39 amRNSHolding(s) in Company
7th Feb 20227:00 amRNSAppointment of CEO
27th Jan 20225:45 pmRNSHolding(s) in Company
26th Jan 20227:00 amRNSPets at Home Group Plc: Q3 FY22 Trading Statement
10th Dec 20214:23 pmRNSHolding(s) in Company
6th Dec 20215:20 pmRNSDirector/PDMR Shareholding
6th Dec 20215:20 pmRNSDirector/PDMR Shareholding
6th Dec 20215:20 pmRNSDirector/PDMR Shareholding
23rd Nov 20217:00 amRNSFY22 Interim Results
3rd Nov 20217:00 amRNSDirectorate Change & Trading Update
26th Oct 202112:48 pmRNSDirector/PDMR Shareholding
26th Oct 202112:47 pmRNSDirector/PDMR Shareholding
16th Sep 20213:10 pmRNSNED Appointment
18th Aug 20214:45 pmRNSDirector/PDMR Shareholding
2nd Aug 20217:00 amRNSDirector/PDMR Shareholding
29th Jul 20217:00 amRNSTrading Statement
21st Jul 20211:08 pmRNSHolding(s) in Company
16th Jul 20219:41 amRNSChange in Director’s details
8th Jul 20213:22 pmRNSResult of AGM
8th Jul 20219:45 amRNSDirector/PDMR Shareholding
16th Jun 20216:18 pmRNSHolding(s) in Company
15th Jun 20215:30 pmRNSHolding(s) in Company
9th Jun 20218:31 amRNSAnnual Report & Accounts and Notice of AGM
4th Jun 20219:38 amRNSDirector/PDMR Shareholding
3rd Jun 202112:22 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.